CHICAGO, December 08, 2025--(BUSINESS WIRE)--Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced the publication of new research in Science ...
The Science Advances publication details Cellgorithmâ„¢, a CRISPR-based technology that gives researchers greater control over gene activity and sets the stage for future applications in stem cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results